Table 2.

Changes in Medication by Patient and Encounter Characteristics if Hemoglobin A1c Value Was Greater Than 7% (n = 98)

CharacteristicChange in Medication Mean (SD) or %No Change in Medication Mean (SD) or %P Value
Hemoglobin A1c=glycosylated hemoglobin.
Patient characteristics
    Age, years57.5 (13.2)56.7 (13.5).76
    Female, %54.950.0.55
    Hispanic, %60.859.6.88
    Number of comorbidities4.8 (2.2)4.3 (1.9).22
    Hemoglobin A1c, %8.6 (2.1)7.3 (1.7)<.001
    Previous hemoglobin A1c level worse, %51.550.9.95
    Number of long-term medications7.09 (3.14)5.51 (2.92).02
Encounter characteristics
    Number of patient concerns1.5 (1.3)2.4 (2.1).04
    Number of topics discussed by physician13.4 (4.49)11.3 (5.05).05
    Length of encounter, minutes19.4 (7.2)15.4 (7.8).02
    Number of days since last measured hemoglobin A1c70.8 (94.8)110.2 (170.5).07
Percentage of encounter devoted to:
    Discussing nutrition5.23 (6.25)2.91 (4.76).07
    Discussing exercise1.50 (2.24)1.71 (3.20).77
    Discussing medication compliance7.47 (6.26)7.79 (6.09).83
Percentage of encounter time until:
    Evaluation/feedback of test results48 (0.29)0.62 (0.80).44
    Discussion of planning treatment74 (0.28)0.80 (0.43).57